Table 2. Chemotherapeutic regimens.
| Neoadjuvant chemotherapy (n = 24) | Therapeutic chemotherapy (n = 17) | |||
|---|---|---|---|---|
|
|
|
|||
| Regimen | Receiving, n (%) | Median cycles (range) | Receiving, n (%) | Median cycles (range) |
| Methotrexate, vinblastine, doxorubicin, cisplatin | 5 (19) | 4 (2–4) | 3 (18) | 4 (4–6) |
| Gemcitabine, cisplatin | 19 (79) | 4 (2–6) | 4 (24) | 5 (2–5) |
| Ifosfamide, paclitaxel, cisplatin | 0 (0) | – – | 2 (12) | 4.5 (4–5) |
| Doxorubicin, gemcitabine, ifosfamide, paclitaxel, cisplatin | 0 (0) | – – | 3 (18) | 4 (4–4) |
| Gemcitabine, cisplatin, paclitaxel | 0 (0) | – – | 2 (12) | 5.5 (5–6) |
| Gemcitabine, carboplatin, paclitaxel | 0 (0) | – – | 2 (12) | 5.5 (5–6) |
| Cyclophosphamide, docetaxel, doxorubicin | 0 (0) | – – | 1 (6) | 6 NA |
NA, not available.